• 1-Sep-2011 Crikey
    New trade agreement threatens Australia’s laws on medicines and tobacco

    Australia leads the world in many areas of public health but the Federal Government could be negotiating our achievements away, according to Dr Patricia Ranald, Convenor, Australian Fair Trade and Investment Network

  • 29-Aug-2011 HealthDev.Net
    ICAAP10 2011: No safe avenue to address your concerns

    The 10th International Conference on AIDS in Asia and the Pacific (ICAAP10) has been turned upside down completely

  • 29-Aug-2011 The Scavenger
    Protestors attacked by police at international AIDS conference

    An anti-Free Trade Agreement protest that took place outside an International Congress on AIDS in the Asia Pacific (ICAAP) in Busan, South Korea, on 27 August was violently attacked by police.

  • 12-Aug-2011 Patent Docs
    House legislators lobby to exclude 12-year data exclusivity period from free trade agreement

    Last week, a group of seven House Democrats, led by Rep. Henry Waxman (D-CA), sought to have the 12-year data exclusivity period provided by the biosimilar approval pathway of the US’ Patient Protection and Affordable Care Act excluded from the Trans-Pacific Partnership agreement

  • 10-Aug-2011 PharmaBiz
    DoP to convey concerns of industry over proposed FTAs, TPPA to commerce ministry

    India’s Department of Pharmaceuticals will take up issues with the Commerce Ministry regarding the proposed Trans Pacific Partnership Agreement which is likely to have adverse impact on the Indian pharma products, and other such Free Trade Agreements in the pipeline.

  • 27-Jul-2011 NY Times
    A trade barrier to defeating AIDS

    The new strategy is to treat people in Egypt, Paraguay, Turkmenistan or China — middle-income countries, all — as if they or their governments could pay hundreds or even thousands of dollars a year each for AIDS drugs.

  • 25-Jul-2011 ULB
    Impact Assessment of CETA IPR chapter

    CETA IPR chapter will likely have a slight positive effect on specific industries in the EU, such as agri-food companies using geographical indications. It would also benefit the Canadian publishing industry and the innovative pharmaceutical industry. At the same time, an IPR chapter in CETA could lead to notable negative effects in Canada, for example via higher prices on educational and pharmaceutical products.

  • 18-Jul-2011 ANGOP
    Président de l’IAS pour plus de facilités d’accès aux médicaments contre le sida

    Le président de l’Association Internationale du Sida (IAS), l’Ougandais Elly Katabira, a invité dimanche, tous les pays du monde de faciliter l’accès aux médicaments contre la maladie, y compris les génériques, par des nouvelles lois ou règlements.

  • 17-Jul-2011
    SOCMA offers support for free trade pacts with South Korea, Panama, and Colombia

    The Society of Chemical Manufacturers and Affiliates (SOCMA) issued its support this week of the passage of pending free-trade agreements (FTA) with South Korea, Panama and Colombia by two Congressional committees. SOCMA is the US-based trade association representing custom and batch manufacturers, including contract manufacturers of fine chemicals, pharmaceutical intermediates, and active pharmaceutical ingredients.

  • 15-Jul-2011 Public Service Europe
    EU-India FTA - the data exclusivity dilemma

    Conflict between European and Indian pharma industries might be played out again in FTAs with other nations

  • 10-Jul-2011
    "BRICS can ensure affordable drugs"

    While ‘data exclusivity’ clauses will not feature in the India-European Union free trade agreement (FTA), the threat posed by the impending deal to the world’s supply of cheap generic drugs is far from over.

  • 8-Jul-2011
    Korea-EU FTA to put Seoul at public health crossroads

    Pharmaceuticals might not have been the most discussed sector before the Korea-European Union Free Trade Agreement came into effect from July 1.

  • 6-Jul-2011 Reuters
    Millions will die if India stops AIDS drugs — UN

    Millions of people dependent on life-saving generic drugs to treat HIV/AIDS will die if India stops producing cheap drugs for the disease due to its trade deal with the European Union, the head of UNAIDS warned on Tuesday.

  • 3-Jul-2011 ACT UP-Paris
    ACT UP-Paris wakes up the European Commissioner for Trade in Belgium

    This morning, in a small town in the region of Gent, Belgium, activists from Act Up-Paris woke up the European Commissioner for Trade in front of his house. They unfurled a banner which said ‘De Gucht, AIDS accomplice’.

  • 29-Jun-2011 Prensa Libre
    EEUU - DR-CAFTA: TLC encarece medicamentos

    El relator especial de las Naciones Unidas sobre el Derecho a la Salud, Anand Grover, detectó el aumento en el precio de algunos medicamentos, debido al TLC con EE. UU., y sugiere la compra de fármacos genéricos.

  • 27-Jun-2011 Alternet
    5 WikiLeaks revelations exposing the rapidly growing corporatism dominating American diplomacy abroad

    One of WikiLeaks’ greatest achievements has been to expose the exorbitant amount of influence that multinational corporations have over Washington’s diplomacy.

  • 27-Jun-2011
    US breaks UN AIDS summit commitment on access to treatment

    The Asia Pacific Network of Positive People (APN+) is expressing outrage at ongoing free trade agreement negotiations by the United States with Vietnam and Malaysia that threaten access to medicines for HIV, TB, hepatitis-C as well as other diseases in these countries.

  • 23-Jun-2011
    The Bangkok Declaration on free trade agreements & access to medicines

    Statement of May 2011 against the increasingly rapid spread of Free Trade Agreements that put the profits of multinational pharmaceutical companies ahead of people’s right to health around the world.

  • 23-Jun-2011 MSF
    India says ‘no’ to policy that would block access to affordable medicines

    India formally announced at the UN High Level Meeting on HIV and AIDS that it will not accept data exclusivity, a provision harmful to access to affordable medicines, as part of a free trade agreement currently being negotiated with the European Union.

  • 16-Jun-2011 Infojustice
    Shape of US TPP pharmaceuticals chapter emerges

    The TPP chapter may be best seen as a significant step toward the pharmaceutical industry’s ultimate goal, which is a binding international agreement on drug pricing that would restrain the ability of governments to use collective purchasing power to demand prices below “market” levels.

  • 0 | ... | 80 | 100 | 120 | 140 | 160 | 180 | 200 | 220 | 240 | ... | 620